Steve F. Poon

512 total citations
15 papers, 364 citations indexed

About

Steve F. Poon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Steve F. Poon has authored 15 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Steve F. Poon's work include Neuroscience and Neuropharmacology Research (5 papers), Chemical Synthesis and Analysis (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Steve F. Poon is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Chemical Synthesis and Analysis (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Steve F. Poon collaborates with scholars based in United States and United Kingdom. Steve F. Poon's co-authors include David H. Drewry, Diane M. Coe, David J. St. Jean, Candy Tsourounis, Leslie Z. Benet, Janice Chung, Merryl Cramer, Nicholas D. P. Cosford, Nicholas D. Smith and Deborah F. Chapman and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Clinical Pharmacology & Therapeutics.

In The Last Decade

Steve F. Poon

14 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve F. Poon United States 9 220 174 41 36 34 15 364
David L. Musso United States 11 145 0.7× 136 0.8× 41 1.0× 47 1.3× 19 0.6× 22 330
J. Bolós Spain 10 214 1.0× 153 0.9× 15 0.4× 35 1.0× 39 1.1× 53 395
Rebecca Fransson Sweden 13 126 0.6× 174 1.0× 102 2.5× 15 0.4× 23 0.7× 23 401
Roy T. Uyeda United States 9 161 0.7× 183 1.1× 38 0.9× 124 3.4× 19 0.6× 15 425
Richard A. Price United Kingdom 9 124 0.6× 142 0.8× 8 0.2× 77 2.1× 39 1.1× 16 311
Andrew J. Kassick United States 11 224 1.0× 160 0.9× 35 0.9× 35 1.0× 6 0.2× 20 434
Denis Har Switzerland 14 328 1.5× 164 0.9× 11 0.3× 17 0.5× 21 0.6× 21 415
Shin-ichiro Matsunaga Japan 13 376 1.7× 252 1.4× 48 1.2× 26 0.7× 17 0.5× 15 660
John Lloyd United States 13 220 1.0× 193 1.1× 22 0.5× 13 0.4× 10 0.3× 21 434
Kosho Makino Japan 12 140 0.6× 95 0.5× 15 0.4× 15 0.4× 20 0.6× 57 374

Countries citing papers authored by Steve F. Poon

Since Specialization
Citations

This map shows the geographic impact of Steve F. Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve F. Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve F. Poon more than expected).

Fields of papers citing papers by Steve F. Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve F. Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve F. Poon. The network helps show where Steve F. Poon may publish in the future.

Co-authorship network of co-authors of Steve F. Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Steve F. Poon. A scholar is included among the top collaborators of Steve F. Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve F. Poon. Steve F. Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Wehn, Paul M., Paul E. Harrington, Timothy J. Carlson, et al.. (2013). Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidism. Bioorganic & Medicinal Chemistry Letters. 23(24). 6625–6628. 8 indexed citations
3.
Ashton, Kate S., David J. St. Jean, Steve F. Poon, et al.. (2011). Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2. Bioorganic & Medicinal Chemistry Letters. 21(18). 5191–5196. 5 indexed citations
4.
Poon, Steve F., David J. St. Jean, Paul E. Harrington, et al.. (2009). Discovery and Optimization of Substituted 1-(1-Phenyl-1H-pyrazol-3-yl)methanamines as Potent and Efficacious Type II Calcimimetics. Journal of Medicinal Chemistry. 52(21). 6535–6538. 17 indexed citations
5.
Poon, Steve F., et al.. (2007). Effects of Uptake and Efflux Transporter Inhibition on Erythromycin Breath Test Results. Clinical Pharmacology & Therapeutics. 81(6). 828–832. 41 indexed citations
6.
Jean, David J. St., et al.. (2007). A Tandem Cross-Coupling/SNAr Approach to Functionalized Carbazoles. Organic Letters. 9(23). 4893–4896. 55 indexed citations
7.
Poon, Steve F., Nicholas Stock, Joseph E. Payne, et al.. (2005). Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor. Bioorganic & Medicinal Chemistry Letters. 15(9). 2259–2263. 7 indexed citations
8.
Tehrani, Lida, Nicholas D. Smith, Dehua Huang, et al.. (2005). 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5061–5064. 10 indexed citations
10.
Poon, Steve F., Brian Eastman, Deborah F. Chapman, et al.. (2004). 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5477–5480. 19 indexed citations
11.
Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2004). 2-{2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5473–5476. 25 indexed citations
12.
Smith, Nicholas D., Steve F. Poon, Dehua Huang, et al.. (2004). Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 14(22). 5481–5484. 12 indexed citations
13.
Drewry, David H., Diane M. Coe, & Steve F. Poon. (1999). ChemInform Abstract: Solid‐Supported Reagents in Organic Synthesis. ChemInform. 30(21).
14.
Drewry, David H., Diane M. Coe, & Steve F. Poon. (1999). Solid-supported reagents in organic synthesis. Medicinal Research Reviews. 19(2). 97–148. 110 indexed citations
15.
Poon, Steve F., et al.. (1989). Film Stress in High Density Thin Film Interconnect. MRS Proceedings. 154. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026